Galia Rahav
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria 5
-
- Antibiotic Use and Resistance 4
- Endocrinology top 5%
- Clinical Biochemistry top 5%
- Bacterial Identification and Susceptibility Testing 4
-
- Antibiotics Pharmacokinetics and Efficacy 4
-
- HIV/AIDS drug development and treatment 3
-
- Pneumocystis jirovecii pneumonia detection and treatment 2
-
- Polyamine Metabolism and Applications 2
-
- Acute Myeloid Leukemia Research 1
Galia Rahav
15 papers receiving 398 citations
Peers
Comparison fields: 5 of 52
- Molecular Medicine 251
- Applied Microbiology and Biotechnology 94
- Endocrinology 101
- Clinical Biochemistry 93
- Pollution 41
Countries citing papers authored by Galia Rahav
This map shows the geographic impact of Galia Rahav's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Galia Rahav with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Galia Rahav more than expected).
Fields of papers citing papers by Galia Rahav
This network shows the impact of papers produced by Galia Rahav. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Galia Rahav. The network helps show where Galia Rahav may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Galia Rahav, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 14 | |
| 3 | Healthcare-associated Pneumocystis jirovecii Pneumonia (PJP) Infection in HIV-negative Adults: a Multicenter Study. | 2021 | 1 |
| 4 | 2019 | 13 | |
| 5 | 2018 | 4 | |
| 6 | 2016 | 24 | |
| 7 | 2016 | 2 | |
| 8 | 2010 | 9 | |
| 9 | 2010 | 140 | |
| 10 | 2009 | 17 | |
| 11 | 2008 | 102 | |
| 12 | 2006 | 1 | |
| 13 | 2005 | 9 | |
| 14 | 2004 | 18 | |
| 15 | 1995 | 5 | |
| 16 | 1990 | 51 | |
| 17 | 1987 | 4 |
About Galia Rahav
Galia Rahav is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Clinical Biochemistry, having authored 17 papers that have together received 414 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (5 papers), Antibiotic Use and Resistance (4 papers), Bacterial Identification and Susceptibility Testing (4 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), HIV/AIDS drug development and treatment (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers), Polyamine Metabolism and Applications (2 papers) and Acute Myeloid Leukemia Research (1 paper). The work is most often cited by research in Molecular Medicine (251 citations), Applied Microbiology and Biotechnology (94 citations) and Endocrinology (101 citations). Galia Rahav has collaborated with scholars based in Israel, Italy and United Kingdom. Frequent co-authors include A. Weiss, Nathan Keller, Ilana Tal, Gill Smollan, Gili Regev‐Yochay, Debby Ben-David, Yasmin Maor, Amir Zlotkin, Musa Hindiyeh and Ari Shamiss. Their work appears in journals such as PLoS ONE, Biochemical and Biophysical Research Communications and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.